GGrantIndex
← Search

Bioscience Screening

$94,736P30FY2017CANIH

Stanford University, Stanford CA

Investigators

Linked publications, trials & patents

Paper 39574895Paper 39534431Paper 39506045Paper 39378093Paper 39257774Paper 39179931Paper 39163262Paper 39132489Paper 39042439Paper 38997156Paper 38996463Paper 38987048Paper 38968138Paper 38838737Paper 38810650Paper 38746193Paper 38563850Paper 38496616Paper 38496500Paper 38408498Paper 38387457Paper 38278150Paper 38273211Paper 38262408Paper 38260330Paper 38200310Paper 38154193Paper 38096469Paper 37963187Paper 37917579Paper 37882771Paper 37812494Paper 37743567Paper 37667254Paper 37662553Paper 37534980Paper 37532139Paper 37527449Paper 37398193Paper 37244414Paper 37196642Paper 37184546Paper 37162847Paper 36999999Paper 36993756Paper 36813894Paper 36747642Paper 36734849Paper 36729432Paper 36729074Paper 36719070Paper 36717409Paper 36711732Paper 36701540Paper 36652552Paper 36640300Paper 36635501Paper 36624348Trial NCT05220254Trial NCT03733210Trial NCT03405142Trial NCT03241940Trial NCT03179449Trial NCT02855086Trial NCT02805075Trial NCT02762266Trial NCT02736578Trial NCT02735356Trial NCT02699723Trial NCT02695628Trial NCT02690948Trial NCT02683824Trial NCT02635074Trial NCT02624518Trial NCT02599194Trial NCT02581787Trial NCT02488070Trial NCT02440308Trial NCT02432118Trial NCT02429804Trial NCT02415608Trial NCT02401347Trial NCT02215928Trial NCT02210858Trial NCT02203565Trial NCT02184533Trial NCT02175745Trial NCT02166983Trial NCT02058550Trial NCT02030405Trial NCT02019069Trial NCT01977677Trial NCT01943188Trial NCT01928030Trial NCT01926990Trial NCT01908166Trial NCT01904643Trial NCT01898403Trial NCT01893892Trial NCT01868503

Abstract

The Bioscience Screening Shared Resource provides researchers at the Stanford Cancer Institute with the ability to run high-throughput chemical, siRNA, cDNA and high-content screens for the purpose of drug discovery and target identification. The Bioscience Screening Shared Resource incorporates instrumentation (purchased with NCRR NIH Instrumentation grants S10RR019513 and S10RR026338), databases, and compound and molecular libraries to allow cancer researchers to discover novel molecular targets and identify small molecules that modulate them. Among the instrumentation in the Bioscience Screening Shared Resource is a High-Content fluorescence microplate imager with live cell and phase contrast/brightfield options, advanced microplate 96- and 384-well head pipetting liquid handlers, and fluorescence, luminescence, and absorbance multimode microplate readers. The facility has over 130,000 small molecules for compound screens, 15,000 human cDNAs for genomic screens, and whole genome siRNA libraries targeting the human genome (the siARRAY whole human genome siRNA library from Dharmacon targeting 21,000 human genes) and the mouse genome (Qiagen mouse whole genome siRNA set V1 against 22,000 genes). Access to the equipment and services are provided efficiently and cost-effectively through the Bioscience Screening Shared Resource. Prior to the facility?s establishment, the cost of doing the majority of these types of experiments at Stanford was prohibitively high. Today, SCI investigators can perform high-throughput screens and use state-of-the art screening equipment for their research on the medical school campus, allowing the discovery of novel cancer targets and potential new therapeutics. This shared resource makes every effort to bring in new technologies, such as whole genome siRNA knockdown screens, and other services to meet the evolving needs of SCI members. In the past five years, investigators from all of the SCI Research Programs have used Bioscience Screening equipment and services for their studies, resulting in important translational discoveries and many publications.

View original record on NIH RePORTER →